Successful Type B RDEP Meeting confirms FDA alignment on pivotal Phase 3 study design FDA indicates Opus Genetics may submit a BLA based on 6-month efficacy data, with 12-month du ...
Nestled on the northeastern fringe of the Tibetan Plateau at an average elevation of 2,800 metres, the Qaidam Basin is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results